Welcome to the Starpharma investor centre.Starpharma Holdings Limited is an Australian stock exchange listed biotechnology company with products based on its dendrimer technology platform. |
 |
Latest News & Announcements
VIRALEZE™ registered in Vietnam with launch this week (ASX Announcement)
Dec 1st, 2021
Starpharma today announced it has received confirmation that VIRALEZE™ antiviral nasal spray has been registered for sale in Vietnam. The product launch is scheduled to occur in Vietnam this week with product supplied under the initial supply distribution arrangements, with Australian-based Healthco Australia Pty Ltd (HealthCo), and Vietnam-based Truong Bao Land International Investment Company Limited (TBL). TBL will also utilise the local medical distribution networks in Vietnam, including Nam Thanh Trade and Medical Services Company Limited.
Read More
AGM Chairman’s address and CEO’s presentation (ASX Announcement)
Nov 30th, 2021
Attached is the Chairman’s address together with the CEO’s presentation to the Annual General Meeting (AGM) of Starpharma Holdings Limited (ASX: SPL, OTCQX: SPHRY), to be held at 11am (Melbourne time) today.
Read More
Starpharma to present at Bell Potter Healthcare Conference (ASX Announcement)
Nov 9th, 2021
Starpharma has been invited to present today at the exclusive virtual 2021 Bell Potter Healthcare Conference. The Bell Potter Healthcare Conference showcases leading companies within the Australian healthcare sector and brings together industry leaders with Bell Potter’s network of international and domestic investors, analysts and advisers. The event is available to live-stream via Bell Potter Client Access on 9 – 11 November.
Read More
Quarterly Cashflow and Activities Report (ASX Announcement)
Oct 29th, 2021
Starpharma today released its Appendix 4C – Quarterly Cashflow Report for the period ended 30 September 2021.
Read MoreReports & Presentations
Click here for financial reports archive
AGM Chairman’s address and CEO’s presentation (ASX Announcement)
Nov 30th, 2021
Attached is the Chairman’s address together with the CEO’s presentation to the Annual General Meeting (AGM) of Starpharma Holdings Limited (ASX: SPL, OTCQX: SPHRY), to be held at 11am (Melbourne time) today.
Read More
Starpharma to present at Bell Potter Healthcare Conference (ASX Announcement)
Nov 9th, 2021
Starpharma has been invited to present today at the exclusive virtual 2021 Bell Potter Healthcare Conference. The Bell Potter Healthcare Conference showcases leading companies within the Australian healthcare sector and brings together industry leaders with Bell Potter’s network of international and domestic investors, analysts and advisers. The event is available to live-stream via Bell Potter Client Access on 9 – 11 November.
Read More
Quarterly Cashflow and Activities Report (ASX Announcement)
Oct 29th, 2021
Starpharma today released its Appendix 4C – Quarterly Cashflow Report for the period ended 30 September 2021.
Read More
Starpharma annual report and full year financial results (ASX Announcement)
Aug 26th, 2021
Starpharma today released its annual report and financial results for the year ended 30 June 2021.
Read More
Starpharma to present at Virtual Life Sciences Investor Forum (ASX Announcement)
Jun 24th, 2021
Starpharma today announced that a presentation by Dr Jackie Fairley, CEO, will be broadcast on Thursday 24 June 2021 (US ET) as part of OTCQX’s Virtual Life Sciences Investor Forum. The Life Sciences Investor Forum is a leading investor conference that is attended by tens of thousands of investors, primarily US-based retail investors, as well as advisors.
Read More